Palvella Therapeutics Inc. (PVLA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Palvella Therapeutics Inc...

    NASDAQ: PVLA · Real-Time Price · USD
    65.78
    3.15 (5.03%)
    At close: Oct 03, 2025, 3:59 PM
    65.91
    0.20%
    After-hours: Oct 03, 2025, 07:44 PM EDT

    Palvella Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.53 1.15 -0.48 -0.3
    PEG Ratio
    		 0.01 -0.01 0.01 -0.08
    PS Ratio
    		 n/a n/a 0.61 0.44
    PB Ratio
    		 0.43 -5.56 -0.68 0.27
    P/FCF Ratio
    		 -2.46 -1.57 -1.07 -1.59
    P/OCF Ratio
    		 -2.46 -1.57 -1.07 -1.79
    OCF/S Ratio
    		 n/a n/a -0.57 -0.24
    Debt / Equity Ratio
    		 n/a n/a n/a 0.29
    Quick Ratio
    		 7.33 3.20 2.86 2.52
    Current Ratio
    		 7.33 3.20 2.86 2.52
    Asset Turnover
    		 n/a n/a 1.57 0.20
    Interest Coverage
    		 -3.26 n/a n/a n/a
    Return on Equity
    		 -0.28 -4.82 1.44 -0.9
    Return on Assets
    		 -0.2 2.48 -2.01 -0.3
    Return on Invested Capital
    		 -0.18 -2.29 -4.05 -0.5
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a 0.89 0.92
    Net Profit Margin
    		 n/a n/a -1.28 -1.46
    Pretax Profit Margin
    		 n/a n/a -1.28 -1.46
    Operating Profit Margin
    		 n/a n/a -1.68 -1.65
    FCF Margin
    		 n/a n/a -0.57 -0.27
    EBITDA Margin
    		 n/a n/a -1.18 -1.38

    Add to Watchlist